News
Press Release | December 9, 2021
Interius BioTherapeutics Announces Granting of US Patent to Support in Vivo Cell-Specific Gene Delivery Platform
News | December 1, 2021
Entrada Therapeutics: Advancing A New Class Of Medicines Called EEV
News | November 12, 2021
ImCheck Provides Promising Updated Patient Response Data from the Phase I/IIa EVICTION Trial with ICT01 at SITC Meeting 2021
News | October 20, 2021
imCheck Publishes Comprehensive Overview of the Developmenet Resumts of its First-in-class Cancer Immunotherapeutic Targeting BTN3A to Activate Cells in Science Translational Medicine
Press Release | October 18, 2021
Dragonfly Therapeutics Announces Sixth Dragonfly Drug to be Licensed by Bristol Myers Squibb and Receipt of Milestone Payments Following First Patient Dosing of Two TriNKET™ Immunotherapies
Press Release | October 11, 2021
Pyxis IPO leads way as four life science firms kick off 4Q, raising nearly $500M
Press Release | October 8, 2021
Precision BioSciences Statement on Safety of its Allogeneic CAR T Cells
Press Release | October 4, 2021
New Study Finds Freenome’s Multiomics Approach Successful in Detecting Pancreatic Cancer
Press Release | October 4, 2021
Research Highlights Freenome’s Blood Test for Colorectal Cancer to Primary Care Physicians
Press Release | October 1, 2021
ImCheck to Present Updated Patient Response Data from the EVICTION Trial and Additional ICT01 Results at the SITC Annual Meeting 2021
News | September 28, 2021
Orbus Therapeutics Granted European Patent for Method of Use for Eflornithine
News | September 17, 2021
DICE Therapeutics Announces Pricing of Upsized Initial Public Offering
News | September 17, 2021
ImCheck Presents Preliminary Patient Response Data from the Phase I/IIa EVICTION Trial with ICT01 at ESMO Congress 2021
1
2